Clinical trials
Phase 1 Cholangiocarcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Unknown status | 4 |
| Completed | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 2 |
| Shanghai Changzheng Hospital | 2 |
| ABM Therapeutics Shanghai Company Limited | 1 |
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 1 |
| Hutchmed | 1 |
| Kinnate Biopharma | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| Shanghai Zhongshan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 17 |
| Stomach Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
| Esophageal Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Biliary Tract Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colonic Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.